Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H9FO2S |
| Molecular Weight | 188.219 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCS(=O)(=O)C1=CC=C(F)C=C1
InChI
InChIKey=PRNNIHPVNFPWAH-UHFFFAOYSA-N
InChI=1S/C8H9FO2S/c1-2-12(10,11)8-5-3-7(9)4-6-8/h3-6H,2H2,1H3
| Molecular Formula | C8H9FO2S |
| Molecular Weight | 188.219 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6618859
Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:01:07 GMT 2025
by
admin
on
Mon Mar 31 18:01:07 GMT 2025
|
| Record UNII |
343BH0S0XR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C65724
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
1214
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
100000080715
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
3235
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
71814
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
2924-67-6
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
C038907
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
343BH0S0XR
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
DTXSID10183494
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
220-889-0
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
SUB07718MIG
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL93309
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | |||
|
m1167
Created by
admin on Mon Mar 31 18:01:07 GMT 2025 , Edited by admin on Mon Mar 31 18:01:07 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |